Clinical trials: Addison Disease

Adrenal Insufficiency

Once-daily Oral Modified Release Hydrocortisone in Patients With Adrenal Insufficiency

• Completed
• Age: 18 years and older
• Phase 2/3
• Pill or oral medicine
• Results posted

This is a randomised, controlled, open, two-armed, two-period cross-over, multi-centre phase II/III study to assess the safety, tolerability and pharmacokinetics of once-daily oral modified-release hydrocortisone in comparison to…

Trial name

NCT00915343

Testing

hydrocortisone (modified release), oral tablet 20 and 5 mg, Hydrocortisone, oral tablet, 10 mg

Volunteers

64 people

Sponsor

Shire